RxDoctor Payments Data

Edward Villella, MD

Vascular Surgery · Beaver, PANPI 1033415732

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,925 of the $3,065 with a category attached, or 62.8%. 14 manufacturers reported payments, led by Silk Road Medical, Inc. at 57.3% of the total. Reporting peaked in 2022 at $1,671 and has fallen 94.9% since, to $85 in 2025. That places this record below the midpoint for vascular surgery clinicians in PA, where the typical reported total is $3,795.

$3,065in general payments, 2019–2025

Across 91 payments — averaging $33.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Silk Road Medical, Inc.$2K
  • W. L. Gore & Associates, Inc.$629
  • Atricure, Inc.$145
  • Edwards Lifesciences$112
  • Medtronic$107
  • Johnson & Johnson$96
  • plus $218 from 8 others

What the payments were for

  • Travel & lodging$1,14037%
  • Food & beverage$1,92563%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,065 in reported general payments places this provider in the 40th percentile of 236 vascular surgery providers in Pennsylvania.

See all vascular surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$50,169
Medicare patients
224
Services billed
376

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate14$119

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Beaver

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →